Amalgamated Bank’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Hold
3,597
﹤0.01% 1546
2025
Q4
$166K Sell
3,597
-112
-3% -$5.01K ﹤0.01% 1604
2025
Q3
$134K Sell
3,709
-592
-14% -$19.6K ﹤0.01% 1651
2025
Q2
$140K Hold
4,301
﹤0.01% 1640
2025
Q1
$162K Buy
4,301
+220
+5% +$17.6K ﹤0.01% 1580
2024
Q4
$334K Hold
4,081
﹤0.01% 1432
2024
Q3
$466K Buy
4,081
+322
+9% +$29K ﹤0.01% 1328
2024
Q2
$284K Buy
3,759
+150
+4% +$10.2K ﹤0.01% 1485
2024
Q1
$247K Sell
3,609
-9,801
-73% -$679K ﹤0.01% 1540
2023
Q4
$842K Sell
13,410
-688
-5% -$35.7K 0.01% 1229
2023
Q3
$719K Buy
14,098
+785
+6% +$38.7K 0.01% 1257
2023
Q2
$665K Buy
13,313
+3,140
+31% +$149K 0.01% 1297
2023
Q1
$381K Sell
10,173
-1,684
-14% -$71.4K ﹤0.01% 1542
2022
Q4
$569K Buy
11,857
+3,263
+38% +$128K 0.01% 1410
2022
Q3
$206K Buy
8,594
+267
+3% +$6.77K ﹤0.01% 1834
2022
Q2
$181K Buy
8,327
+2,970
+55% +$68.7K ﹤0.01% 1912
2022
Q1
$129K Buy
+5,357
New +$117K ﹤0.01% 2103

Other funds holding PCVX